Nucleofection mediates high-efficiency stable gene knockdown and transgene expression in human embryonic stem cells

被引:46
作者
Hohenstein, Kristi A. [1 ,2 ]
Pyle, April D. [3 ]
Chern, Jing Yi [4 ]
Lock, Leslie F. [2 ]
Donovan, Peter J. [2 ]
机构
[1] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Program, Dept Biol Chem, Dev & Cell Biol Dept,Ctr Mol & Mitochondrial Med, Irvine, CA 92697 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Univ Calif Los Angeles, McKusick Nathans Inst Genet Med, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA USA
关键词
human embryonic stem cells; nucleofection; transfection; transgene expression; RNA interference; green fluorescent protein; Oct4; Nanog;
D O I
10.1634/stemcells.2007-0857
中图分类号
Q813 [细胞工程];
学科分类号
摘要
High-efficiency genetic modification of human embryonic stem (hES) cells would enable manipulation of gene activity, routine gene targeting, and development of new human disease models and treatments. Chemical transfection, nucleofection, and electroporation of hES cells result in low transfection efficiencies. Viral transduction is efficient but has significant drawbacks. Here we describe techniques to transiently and stably express transgenes in hES cells with high efficiency using a widely available vector system. The technique combines nucleofection of single hES cells with improved methods to select hES cells at clonal density. As validation, we reduced Oct4 and Nanog expression using siRNAs and shRNA vectors in hES cells. Furthermore, we derived many hES cell clones with either stably reduced alkaline phosphatase activity or stably overexpressed green fluorescent protein. These clones retained stem cell characteristics (normal karyotype, stem cell marker expression, self-renewal, and pluripotency). These studies will accelerate efforts to interrogate gene function and define the parameters that control growth and differentiation of hES cells.
引用
收藏
页码:1436 / 1443
页数:8
相关论文
共 42 条
[11]   Gap junctions and connexon hemichannels in human embryonic stem cells [J].
Huettner, James E. ;
Lu, Aiwu ;
Qu, Yun ;
Wu, Yingji ;
Kim, Mijeong ;
McDonald, John W. .
STEM CELLS, 2006, 24 (07) :1654-1667
[12]   Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells [J].
Inzunza, J ;
Gertow, K ;
Strömberg, MA ;
Matilainen, E ;
Blennow, E ;
Skottman, H ;
Wolbank, S ;
Ährlund-Richter, L ;
Hovatta, O .
STEM CELLS, 2005, 23 (04) :544-549
[13]   Human embryonic stem cell technology [J].
Jones, JM ;
Thomson, JA .
SEMINARS IN REPRODUCTIVE MEDICINE, 2000, 18 (02) :219-223
[14]  
Kobayashi Naoya, 2005, Birth Defects Res C Embryo Today, V75, P10, DOI 10.1002/bdrc.20031
[15]   Transduction of human embryonic stem cells by ecotropic retroviral vectors [J].
Koch, Philipp ;
Siemen, Henrike ;
Biegler, Andrea ;
Itskovitz-Eldor, Joseph ;
Brustle, Oliver .
NUCLEIC ACIDS RESEARCH, 2006, 34 (18)
[16]   Efficient transfection of embryonic and adult stem cells [J].
Lakshmipathy, U ;
Pelacho, B ;
Sudo, K ;
Linehan, JL ;
Coucouvanis, E ;
Kaufman, DS ;
Verfaillie, CM .
STEM CELLS, 2004, 22 (04) :531-543
[17]   Nucleoporation of dendritic cells: efficient, gene transfer by electroporation into human monocyte-derived dendritic cells [J].
Lenz, P ;
Bacot, SM ;
Frazier-Jessen, MR ;
Feldman, GM .
FEBS LETTERS, 2003, 538 (1-3) :149-154
[18]   Therapeutic potential of embryonic stem cells [J].
Lerou, PH ;
Daley, GQ .
BLOOD REVIEWS, 2005, 19 (06) :321-331
[19]   Transient and stable transgene expression in human embryonic stem cells [J].
Liew, Chee-Gee ;
Draper, Jonathan S. ;
Walsh, James ;
Moore, Harry ;
Andrews, Peter W. .
STEM CELLS, 2007, 25 (06) :1521-1528
[20]   High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors [J].
Ma, Y ;
Ramezani, A ;
Lewis, R ;
Hawley, RG ;
Thomson, JA .
STEM CELLS, 2003, 21 (01) :111-117